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Abstract Temperament is considered as a biological disposition reflected by relatively
stable features related to mood and reactivity to external and internal stimuli, including
variability in emotional reactions. The aim of the present study is to test the hypothesis that
affective temperaments might differ according to co-occurring mood disorders among
patients with alcohol and/or opiate dependence; to explore the relationship between tem-
peraments and dual substance use disorders (SUDs, alcohol and other drugs). Ninety-two
patients attending an alcohol addiction treatment facility and 47 patients in an opiate
addiction treatment facility were assessed for SUDs, mood disorders and affective temper-
aments using the Temperament Evaluation of Memphis, Pisa, Paris and San Diego 39-item
auto-questionnaire. Comparison of patients with bipolar disorder, depressive unipolar dis-
order and no (or substance-induced) mood disorder revealed significant differences for the
cyclothymic subscale, with highest scores among patients with bipolar disorder. No differ-
ence was observed for the depressive, irritable, hyperthymic and anxious subscales. After
adjustment for age, gender and bipolar disorder, irritable temperament was a significant risk
factor for past or present history of drug use disorders in patients treated for alcohol addiction
(odds ratio [OR] 1.42, 95 % confidence interval [CI] 1.05–1.93). Anxious temperament was
a significant risk factor for history of alcohol use disorders in patients treated for opiate
addiction (OR 3.30, 95 % CI 1.36–7.99), whereas the hyperthymic subscale appeared as a
significant protective factor (OR 0.65, 95 % CI 0.42–0.99). The results highlight the need to
consider temperamental aspects in further research to improve the long-term outcome of
patient with addictive disorders, who often present complex comorbidity patterns.
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Introduction
A strong association between substance use disorders (SUDs) and mood and anxiety
disorders was found repetitively in epidemiological and clinical studies [1–4].This asso-
ciation can be tentatively explained in a number of ways. For example, affect plays an
important role in motivated behaviors [5], impulsivity and decision-making [6, 7]. In
people with SUDs, affective states and emotional distress as well as expectancy of positive
affective modifications are associated with substance use or relapse [8]. Moreover, it has
been shown that the neural circuitry involved in affective regulation is closely related to
the circuitry underlying addictive behaviors [5, 9].
In consideration of the above arguments, factors influencing affective states may be of
high importance for the understanding and treatment of SUDs. Among these factors,
affective temperaments provide information on individual traits related to tendencies to
experience particular affective states [5]. Temperament is defined as a biological disposition
reflected by relatively stable features related to mood, attitudes towards the environment and
reactivity to external and internal stimuli, including variability and intensity in emotional
dispositions [10, 11]. Temperaments might play a role as prognostic and therapeutic vari-
ables in patients with affective disorders [10]. Within this framework, Akiskal et al. [12]
developed the TEMPS-A (Temperament Evaluation of Memphis, Pisa, Paris and San
Diego), a 39-item self-report, which assesses affective temperaments along the five dimen-
sions of cyclothymia, depression, irritability, hyperthymia and anxiety. The TEMPS-A
is considered to measure stable traits [13]. The hypothesis was raised that a gradient in
subscale scores might exist, from subjects affected with bipolar I disorder, to -II disorder,
major depressive disorder and healthy controls, but results have been inconsistent [14].
A limited number of studies focused on the relationship between temperaments and
addictive behaviors. On the one hand, patients with alcohol dependence scored signifi-
cantly higher than controls on the cyclothymic and depressive scales, regardless of
comorbid axis I disorders [15]. A recent study [16] found an association between cyclo-
thymic temperament and earlier onset of alcohol abuse and dependence. In addition,
anxious temperament was associated with increased probability of previous treatment for
alcohol dependence, whereas depressive temperament was associated with previous sui-
cide attempts. On the other hand, patients with heroin addiction displayed significantly
higher cyclothymic and irritability scores than controls, independently of the presence or
absence of other axis I disorders [17]. It was also reported that patients with heroin
addiction obtained higher scores on the anxious, depressive, cyclothymic and irritable
temperaments than randomly selected non-users matched by age and sex [18].
Previous studies thus strongly suggest that temperaments may play key roles in SUDs.
To our knowledge, the influence of temperaments in dual SUDs (i.e. alcohol and other
substances) has not been investigated so far, even though factors underlying multiple SUDs
might be of particular concern for the treatment of addiction [19]. For example, alcohol
dependence in patients treated for opiate addiction has a major impact on outcome: lower
response to methadone substitution [20–22], lower quality of life [23], and more impulsive
behaviors [24].
Aims of the present study in patients with alcohol and/or opiate dependence were
twofold. The first objective was to test the hypothesis that differences in TEMPS-A
dimensions according to co-occurring mood disorders would be consistent with observa-
tions in non-SUD patients. Its second aim was to investigate temperaments in dual SUDs,
whether substance use among patients treated for alcohol addiction or alcohol use among
the ones treated for opiate addiction.
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Methods
Study Design
The present investigation is part of a study aimed at screening for bipolar disorder among
outpatients with SUDs [25]. The study was conducted at the Department of Mental Health
and Psychiatry, Geneva University Hospitals, in two community outpatient facilities that
are specialized for the treatment of alcohol and opiate dependence, respectively. Partici-
pants were recruited among patients newly referred for treatment or already in contact with
these facilities.
Inclusion criteria were alcohol or opiate dependence according to DSM-IV. Exclusion
criteria were age under 18 years, previous treatment in a specialized unit for mood dis-
orders, insufficient mastery of French, and incapacity to give informed consent.
The study protocol was accepted by the Ethics Committee of the Psychiatry Department
of the Geneva University Hospitals. Written informed consent was obtained from each
participant before inclusion.
Instruments and Procedure
After providing written informed consent, patients met a research psychologist, who was
not involved in patients’ care and was well trained with study instruments. Assessments
were performed during two sessions within a period of 2–4 weeks. Demographic data were
collected at study inclusion and information about medication was retrieved in patients’
charts.
The TEMPS-A is a self-report questionnaire designed to measure temperamental
variations in psychiatric patients and healthy volunteers [26]. It includes 39 yes/no items
used to quantify five affective temperaments: cyclothymic (12 items), depressive (8 items),
hyperthymic (8 items), irritable (8 items), and anxious (3 items). The French version of the
TEMPS-A has been validated and showed a five-factor structure consistent with the ori-
ginal English version [27].
The Addiction Severity Index (ASI) is a multidimensional semi-structured clinical
interview designed to detect and measure the severity of problems in seven areas com-
monly affected by alcohol and drug dependence: medical, employment/support, alcohol
and drug use, legal, family history, family/social relationships and psychiatric problems
[28]. Only the section about alcohol and drug consumption was used in the present study.
Dual SUD was recorded on the basis of the grid concerned with lifetime use of alcohol and
different drugs: it was assumed to be positive when at least 1 of 2 items about alcohol and 1
of 10 items about other substances were checked positive (i.e. at least 1 year of regular or
problematic use for both alcohol and other substances, independently of whether or not
they co-occurred). Duration of use was estimated as the longest duration if multiple
substances were cited.
Diagnosis of alcohol or substance dependence was established according to the DSM-IV
criteria by psychiatry residents and a senior psychiatrist. All patients recruited in the
alcohol treatment facility met DSM-IV criteria for alcohol dependence, and all patients in
the opiate addiction treatment facility met criteria for opiate dependence. Mood disorders
were diagnosed according to the Structured Clinical Interview for DSM-IV Axis I Dis-
orders (SCIDs) [29]. Other axes I and II disorders were not assessed.
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Statistical Analysis
Group comparison proceeded with the Fisher’s exact test for categorical variables and the
Mann–Whitney U test (two groups) or Kruskal–Wallis analysis of variance (three groups)
for continuous and ordinal variables. In the latter case, post hoc analyses were performed
using Bonferroni correction for multiple testing. The association between dual SUD and
TEMPS-A dimensions was investigated with univariate and multivariate logistic regres-
sion. Multivariate models were adjusted for age (\45 vs. C45 years), sex and diagnosis of
bipolar disorder. Unadjusted and adjusted odds ratios (ORs) and 95 % confidence intervals
(95 % CIs) were estimated. Statistical significance was set at 0.05 (two-tailed tests). Data
analysis was performed using SPSS version 17 (SPSS Inc., Chicago IL, USA).
Results
Comparison of patients treated for alcohol dependence (n = 92) and opiate dependence
(n = 47) is provided in Table 1. Patients in the opiate addiction treatment facility were
significantly younger, and more frequently single and unemployed. Distribution of
comorbid mood disorders significantly differed in the two facilities, with higher frequency
of unipolar depressive disorders among patients treated for alcohol dependence (57.6 vs.
29.8 %), but similar frequencies of bipolar disorders (21.7 vs. 23.4 %). Of 31 patients
within the bipolar spectrum, 2 were diagnosed with bipolar I disorder, 22 with bipolar II
disorder and 7 with bipolar disorder not otherwise specified. Antidepressants were more
often prescribed in the alcohol treatment facility. Antipsychotic drugs were more frequent
in the opiate addiction facility, where a majority of patients had methadone maintenance
treatment (95.7 %). As expected, patients treated for alcohol dependence had significantly
higher alcohol use composite scores according to the ASI, with a median 15 years lifetime
use of alcohol. Conversely, patients treated for opiate addiction had higher drug use
composite scores, with a median 15 years lifetime use of drugs (if multiple substances
were used, longest duration was considered). Prevalence of dual SUDs was 52.2 % in the
alcohol addiction facility (median lifetime use of drugs 9.5 years, range 1–35), with lon-
gest duration most often reported for cannabis (30.4 %) and sedatives, hypnotics and
tranquilizers (13.0 %). Prevalence of dual SUDs was 61.1 % in the opiate addiction facility
(mostly alcohol: median lifetime use of alcohol 7.5 years, range 1–22).
Patients treated for alcohol and opiate dependence did not significantly differ for any of
the five TEMPS-A subscales (not shown). Scores did not significantly differ according to
gender, except for higher anxious temperament in women than in men (median 2 vs. 1,
p = 0.014). Age was not associated with temperament, with the exception of the cyclo-
thymic score that was significantly higher among patients less than 45 years old (median
scores 7 vs. 5, p = 0.030).
Differences between patients with bipolar disorder, depressive unipolar disorder and no
(or substance-induced) mood disorder are documented in Table 2. In both facilities, sig-
nificant differences were observed across the three diagnostic groups for the cyclothymic
subscale and highest scores were obtained among patients with bipolar disorder. No dif-
ference was observed for the depressive, irritable, hyperthymic and anxious subscales.
The association between dual SUDs and temperaments is documented in Table 3. In the
alcohol addiction treatment facility, use of other substances was associated with cyclo-
thymic and irritable temperaments in univariate models. Irritable temperament remained a
significant risk factor for drug use after adjustment for age, gender and bipolar disorder
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(OR 1.42, 95 % CI 1.05–1.93). In the opiate addiction treatment facility, alcohol use was
associated with anxious temperament in univariate models. The anxious subscale remained
a significant risk factor for alcohol use in the multivariate model (OR 3.30, 95 % CI
1.36–7.99), whereas the hyperthymic subscale appeared as a significant protective factor
(OR 0.65, 95 % CI 0.42–0.99).
Table 1 Patient characteristics (n = 139)
Alcohol addiction treatment
facility (n = 92)
Opiate addiction treatment
facility (n = 47)
p valuea
Age (median, range) 49 (29–70) 36 (22–53) \0.001
Gender (n, %) 0.10
Men 50 (54.3) 33 (70.2)
Women 42 (45.7) 14 (29.8)
Marital status (n, %) 0.017
Single 33 (35.9) 29 (61.7)
Married 19 (20.7) 6 (12.8)
Separated/divorced/
widowed
40 (43.5) 12 (25.5)
Occupation (n, %) \0.001
Employed 39 (42.4) 4 (8.5)
Unemployed 53 (57.6) 43 (91.5)
Medication (n, %)
Antidepressant 58 (63.0) 16 (34.0) 0.002
Antipsychotic 11 (12.0) 17 (36.2) 0.001
Mood stabilizer 7 (7.6) 6 (12.8) 0.36
Tranquillizer 38 (41.3) 23 (48.9) 0.47
Hypnotic 15 (16.3) 9 (19.1) 0.81
Methadone 4 (4.3) 45 (95.7) \0.001
SCID diagnosis (n, %) 0.005
Bipolar disorder 20 (21.7) 11 (23.4)
Depressive unipolar
disorder
53 (57.6) 14 (29.8)
Substance-induced
mood disorder
7 (7.6) 6 (12.8)
No mood disorder 12 (13.0) 16 (34.0)
ASI (median, range)
Alcohol use composite
score
0.21 (0–0.89) 0.03 (0–0.98) \0.001
Drug use composite
score
0 (0–0.38) 0.25 (0.08–0.42) \0.001
Lifetime use of alcohol
(years)
15 (1–50) 2 (0–22) \0.001
Lifetime use of drugsb
(years)
1.5 (0–35) 15 (1–30) \0.001
SCID Structured Clinical Interview for DSM-IV Axis I Disorders, ASI Addiction Severity Index
a Fisher’s exact test for categorical variables; Mann–Whitney U test for continuous variables
b If multiple substances are used, longest duration is reported
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Discussion
As previously reported [2, 4, 30], mood disorders were frequent in the present study.
Cyclothymic temperament was associated with mood disorders in both addiction treatment
facilities, with highest scores among patients with bipolar disorder (mostly bipolar II). This
result is in line with a review of TEMPS-A data showing significant differences between
bi- and unipolar disorders in most studies [14]. In a large sample of more than 900 subjects,
Di Florio et al. also tested the hypothesis of a gradient in affective temperaments from
bipolar I, to -II, major depressive disorder, and normal control group. In contrast with this
hypothesis, patients with bipolar II disorder had higher median cyclothymic scores than
patients with either bipolar I or recurrent major depressive disorder, but differences were
not significant after adjustment for potential confounders. In patients with recurrent
depressive disorder, cyclothymic temperament was associated with factors considered as
predictive of bipolarity, such as early age of onset, high number of depressive episodes,
psychotic and atypical features and suicidal behavior [31]. Several familial genetic
investigations and treatment responses studies in clinical populations suggested a contin-
uum between cyclothymic temperament, bipolar II disorder and -I disorder [32, 33].
According to Hantouche et al. [34] assessing cyclothymic temperament might be a major
clue for differentiating bipolar II from unipolar patients.
In the present study, a dual SUD was present in more than 50 % of patients attending
alcohol and opiate treatment facilities. A recent review revealed that comorbidity of
alcohol and illicit SUDs is consistently high across studies and emphasized that complex
patterns of comorbidity remained a significant challenge to clinicians and researchers [35].
Table 2 Temperament profiles according to co-occurrence of mood disorders (n = 139)
Bipolar
disorder
Depressive
unipolar
disorder
No or substance-
induced mood
disorder
p valuea
Alcohol addiction facility (n = 20) (n = 53) (n = 19)
TEMPS-A cyclothymic 7 (2–12)b 4 (0–12) 4 (0–10) 0.005
TEMPS-A depressive 2 (0–8) 2 (0–8) 2 (0–7) 0.59
TEMPS-A irritable 2 (0–8) 1 (0–6) 1 (0–8) 0.069
TEMPS-A hyperthymic 4.5 (1–8) 4 (0–8) 5 (0–8) 0.71
TEMPS-A anxious 1 (0–3) 2 (0–3) 1 (0–3) 0.38
Opiate addiction facility (n = 11) (n = 14) (n = 22)
TEMPS-A cyclothymic 10 (1–12)c 6.5 (1–11) 6 (1–12) 0.041
TEMPS-A depressive 4 (1–8) 2 (0–7) 2.5 (0–7) 0.19
TEMPS-A irritable 2 (0–6) 2 (0–7) 1.5 (0–8) 0.22
TEMPS-A hyperthymic 6 (4–8) 5 (2–8) 4.5 (0–8) 0.14
TEMPS-A anxious 2 (0–3) 1.5 (0–3) 1 (0–3) 0.47
TEMPS-A Temperament Evaluation of Memphis, Pisa, Paris and San Diego
a Kruskal–Wallis ANOVA
b Post hoc tests: p = 0.015 versus depressive unipolar disorder; p = 0.010 versus no or substance-induced
mood disorder
c Post hoc tests: p = 0.44 versus depressive unipolar disorder; p = 0.035 versus no or substance-induced
mood disorder
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Studies about the possible association of affective temperaments and substance use have
been sparse and, as far as we know, the role of temperament in relation with dual SUDs has
not been investigated so far. After adjustment for age, gender and bipolar disorder, we
observed that past or present use of other substances was associated with irritable tem-
perament among patients recruited in the alcohol treatment facility, whereas alcohol use
was associated with anxious temperament among patients treated in the opiate addiction
facility. It should be pointed out that possible confounding effects of anxiety and/or per-
sonality disorders cannot be excluded in the present study, in the absence of a more
thorough structured assessment of these diagnoses. On the one hand, irritable and cyclo-
thymic temperaments allowed distinguishing between a sample of people with heroin
addiction and control subjects [17]. Irritable temperament was associated with self-
reported nicotine dependence, alcohol abuse and cannabis use among Austrian college
students [36]. In a study on psychiatric aspects of HIV-related diseases, an irritable-
explosive temperament was associated with heavy use of alcohol, cocaine, and other
stimulants [37]. On the other hand, several studies addressed the self-medication
hypothesis of alcohol or drugs being used in an attempt to reduce anxiety. According to a
large epidemiological study, prevalence of self-medication with alcohol was 18.3 % for
generalized anxiety disorder, whereas self-medication with both alcohol and drugs was
14.9 % for panic disorder with agoraphobia [38]. Among patients enrolled in a methadone
maintenance treatment program, screening positive for social phobia was significantly
associated with alcohol use, whereas both generalized anxiety disorder and social phobia
were associated with the use of non-prescribed benzodiazepines [39]. The hypothesis that
associations between dual SUDs and temperaments might be, at least in part, linked to
attempts to ‘‘self-medicate’’ deserves further investigation in prospective studies and large,
well-characterized samples.
Table 3 Association of dual SUDs and temperament profiles in patients treated for alcohol or opiate
addiction (n = 139)
Dual SUDs (univariate
logistic regression)
Dual SUDs (multivariate
logistic regressiona)
OR 95 % CI p value OR 95 % CI p value
Alcohol addiction treatment facility (n = 92; n = 48 with dual SUDs)
TEMPS-A cyclothymic 1.14 1.00–1.30 0.046 0.95 0.77–1.17 0.63
TEMPS-A depressive 1.18 0.98–1.42 0.088 1.16 0.86–1.55 0.33
TEMPS-A irritable 1.38 1.09–1.74 0.007 1.42 1.05–1.93 0.024
TEMPS-A hyperthymic 0.96 0.81–1.15 0.67 0.90 0.72–1.13 0.37
TEMPS-A anxious 0.88 0.61–1.26 0.48 0.68 0.42–1.09 0.11
Opiate addiction treatment facility (n = 47; n = 32 with dual SUDs)
TEMPS-A cyclothymic 1.09 0.91–1.31 0.36 1.14 0.86–1.50 0.36
TEMPS-A depressive 1.16 0.89–1.52 0.27 0.85 0.55–1.31 0.46
TEMPS-A irritable 1.07 0.79–1.44 0.68 0.94 0.58–1.53 0.81
TEMPS-A hyperthymic 0.79 0.58–1.08 0.13 0.65 0.42–0.99 0.046
TEMPS-A anxious 2.08 1.13–3.85 0.020 3.30 1.36–7.99 0.008
TEMPS-A Temperament Evaluation of Memphis, Pisa, Paris and San Diego, OR odds ratio, CI confidence
interval
a Adjusted for sex, age and bipolar disorder
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Several limitations of this study deserve consideration. First, representativity of the
study samples might be limited, due to non-random recruitment in specialized facilities.
Second, sample size and statistical power were limited, in particular with respect to the
investigation of complex comorbidities. A third limitation is related to the cross sectional
design of the study, that did not allow considering the time course of the association
between dual SUDs and temperaments. Fourth, in the absence of a comprehensive diag-
nostic assessment, the study did not allow distinguishing between the roles of actual
anxiety or personality disorders and the ones of subthreshold stable traits such as
temperaments.
Conclusion
In conclusion, the present results support the relevance of the cyclothymic temperament as
a possible marker of comorbid bipolar disorder, and bipolar II in particular, among patients
attending alcohol and opiate treatment facilities. Furthermore, they suggest that irritable
and anxious affective temperaments, irrespectively of a comorbid bipolar disorder, may
play a key role in dual SUDs. Our results highlight the need to consider temperamental
aspects in further research to improve the long-term outcome of patient with addictive
disorders, who often present complex comorbidity patterns.
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